Free Trial

Cardinal Health (NYSE:CAH) Shares Gap Down - Here's What Happened

Cardinal Health logo with Medical background

Key Points

  • Cardinal Health's stock price gapped down significantly from $157.66 to $140.99 before opening, leading to a last traded price of $143.11 with a volume of over 1.7 million shares.
  • Several analysts have issued mixed ratings for Cardinal Health, with ratings ranging from "neutral" and "buy" to "strong-buy," with a consensus rating of "Moderate Buy" and an average target price of $158.07.
  • The company recently reported quarterly earnings of $2.08 per share, surpassing expectations but falling short on revenue, which was $60.16 billion compared to the anticipated $60.91 billion.
  • Looking to export and analyze Cardinal Health data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Cardinal Health, Inc. (NYSE:CAH - Get Free Report)'s stock price gapped down before the market opened on Tuesday . The stock had previously closed at $157.66, but opened at $140.99. Cardinal Health shares last traded at $143.11, with a volume of 1,757,420 shares changing hands.

Analyst Ratings Changes

CAH has been the topic of several recent analyst reports. Citigroup reaffirmed a "neutral" rating and issued a $170.00 price target (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Wall Street Zen cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 2nd. Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research report on Tuesday. Wells Fargo & Company upgraded shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $136.00 to $179.00 in a report on Tuesday, June 3rd. Finally, Evercore ISI reaffirmed an "outperform" rating and set a $180.00 price objective (up previously from $175.00) on shares of Cardinal Health in a research report on Thursday, June 12th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $158.07.

View Our Latest Analysis on CAH

Cardinal Health Stock Performance

The firm has a 50 day moving average price of $160.10 and a two-hundred day moving average price of $144.16. The company has a market capitalization of $34.88 billion, a P/E ratio of 22.82, a price-to-earnings-growth ratio of 1.56 and a beta of 0.67.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to analysts' expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. The company's quarterly revenue was up .5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.84 earnings per share. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Institutional Trading of Cardinal Health

Hedge funds and other institutional investors have recently modified their holdings of the stock. CenterBook Partners LP acquired a new position in Cardinal Health during the 2nd quarter valued at about $3,705,000. AlphaCore Capital LLC bought a new stake in shares of Cardinal Health during the second quarter worth approximately $41,000. Mufg Securities Americas Inc. lifted its holdings in Cardinal Health by 23.7% in the second quarter. Mufg Securities Americas Inc. now owns 5,290 shares of the company's stock valued at $889,000 after buying an additional 1,014 shares during the period. AXQ Capital LP lifted its holdings in Cardinal Health by 87.0% in the second quarter. AXQ Capital LP now owns 7,048 shares of the company's stock valued at $1,184,000 after buying an additional 3,279 shares during the period. Finally, Journey Strategic Wealth LLC bought a new position in Cardinal Health in the second quarter valued at approximately $223,000. Institutional investors and hedge funds own 87.17% of the company's stock.

About Cardinal Health

(Get Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines